Helsinn Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HELSINN, and when can generic versions of HELSINN drugs launch?
HELSINN has six approved drugs.
There are forty-four US patents protecting HELSINN drugs.
There are three hundred and eighty-one patent family members on HELSINN drugs in sixty-one countries and thirty-five supplementary protection certificates in fifteen countries.
Summary for Helsinn
| International Patents: | 381 |
| US Patents: | 44 |
| Tradenames: | 4 |
| Ingredients: | 5 |
| NDAs: | 6 |
| PTAB Cases with Helsinn as patent owner: | See PTAB cases with Helsinn as patent owner |
Drugs and US Patents for Helsinn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Helsinn | VALCHLOR | mechlorethamine hydrochloride | GEL;TOPICAL | 202317-001 | Aug 23, 2013 | RX | Yes | Yes | 9,382,191 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | RX | Yes | Yes | 12,042,494 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | CAPSULE;ORAL | 022233-001 | Aug 22, 2008 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | DISCN | Yes | No | 7,947,725*PED | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | RX | Yes | Yes | 9,951,016 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | ||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | DISCN | Yes | No | 7,947,724*PED | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Helsinn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | 9,457,020*PED | ⤷ Subscribe |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 9,173,942*PED | ⤷ Subscribe |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | 9,439,854*PED | ⤷ Subscribe |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 7,947,724*PED | ⤷ Subscribe |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | 7,960,424*PED | ⤷ Subscribe |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 8,518,981*PED | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Helsinn Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Norway | 329500 | ⤷ Subscribe |
| Portugal | 2722045 | ⤷ Subscribe |
| South Korea | 20170063768 | ⤷ Subscribe |
| Chile | 2016001436 | ⤷ Subscribe |
| Eurasian Patent Organization | 014066 | ⤷ Subscribe |
| Denmark | 3494960 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Helsinn Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1035115 | CR 2015 00044 | Denmark | ⤷ Subscribe | PRODUCT NAME: NETUPITANT; REG. NO/DATE: EU/1/15/1001 20150529 |
| 1858864 | 36/2017 | Austria | ⤷ Subscribe | PRODUCT NAME: CHLORMETHIN; REGISTRATION NO/DATE: EU/1/16/1171 (MITTEILUNG) 20170307 |
| 1858864 | 17C1029 | France | ⤷ Subscribe | PRODUCT NAME: CHLORMETHINE ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES,EN PARTICULIER LE CHLORHYDRATE.; REGISTRATION NO/DATE: EU/1/16/1171 20170307 |
| 2785706 | SPC/GB20/037 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: FOSNETUPITANT; REGISTERED: UK EU/1/15/1001 (NI) 20200318; UK PLGB 12333/0017-0001 20200318 |
| 1858864 | LUC00033 | Luxembourg | ⤷ Subscribe | PRODUCT NAME: CHLORMETHINE ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (LEDAGA); AUTHORISATION NUMBER AND DATE: EU/1/1671171 20170307 |
| 2785706 | 2020030 | Norway | ⤷ Subscribe | PRODUCT NAME: FOSNETUPITANT OG FARMASOEYTISK AKSEPTABLE SALTER OG SOLVATER DERAV SPESIELT FOSNETUPITANT KLORID HYDROKLORID; REG. NO/DATE: EU/1/15/1001 20200318 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
